Clinical trial
Choosing an Access for Endovascular Treatment of Femoral-popliteal Segment Occlusions
NCT07694050 is registered in ClinicalTrials.gov with Pirogov Russian National Research Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Choosing an Access for Endovascular Treatment of Femoral-popliteal Segment Occlusions
- Lead sponsor
- Pirogov Russian National Research Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2024
- Completion date
- June 18, 2026
- Enrollment
- 304 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brachial access, femoral access, occlusion of the femoral-popliteal segment